Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.
Pharmacy Department, Flinders Medical Centre, Bedford Park, South Australia, Australia.
Br J Clin Pharmacol. 2020 Dec;86(12):2414-2423. doi: 10.1111/bcp.14345. Epub 2020 Jun 1.
To determine the prevalence of potentially inappropriate medication (PIM) use at hospital admission and discharge, and the contribution to hospital admission among residential aged care facility residents with and without dementia.
We conducted a secondary analysis using data from a multihospital prospective cohort study involving consecutively admitted older adults, aged 75 years or older, who were taking 5 or more medications prior to hospital admission and discharged to a residential aged care facility in South Australia. PIM use was identified using the 2015 Screening Tool for Older Persons' Prescription and 2019 Beers criteria. An expert panel of clinicians with geriatric medicine expertise evaluated the contribution of PIM to hospital admission.
In total, 181 participants were included, the median age was 87.5 years and 54.7% were female. Ninety-one (50.3%) had a diagnosis of dementia. Participants with dementia had fewer PIMs, according to at least 1 of the 2 screening criteria, than those without dementia, at admission (dementia: 76 [83.5%] vs no dementia: 84 [93.3%], P = .04) and discharge (78 [85.7%] vs 83 [92.2%], P = .16). PIM use was causal or contributory to the admission in 28.1% of study participants (n = 45) who were taking at least 1 PIM at admission.
Over 80% of acutely admitted older adults took PIMs at hospital admission and discharge and for over a quarter of these people the admissions were attributable to PIM use. Hospitalisation presents an opportunity for comprehensive medication reviews, and targeted interventions that enhance such a process could reduce PIM use and related harm.
确定患有和不患有痴呆症的养老院居民在入院和出院时潜在不适当药物(PIM)的使用情况及其对入院的影响。
我们使用一项多医院前瞻性队列研究的数据进行了二次分析,该研究涉及连续入院的年龄在 75 岁或以上、入院前服用 5 种或更多药物且出院到南澳大利亚养老院的老年人。使用 2015 年老年人处方筛选工具和 2019 年 Beers 标准来确定 PIM 的使用情况。具有老年医学专业知识的临床专家小组评估了 PIM 对入院的影响。
共纳入 181 名参与者,中位年龄为 87.5 岁,54.7%为女性。91 名(50.3%)患有痴呆症。根据至少一种筛选标准,患有痴呆症的患者在入院时(痴呆症:76 [83.5%] vs 无痴呆症:84 [93.3%],P =.04)和出院时(痴呆症:78 [85.7%] vs 无痴呆症:83 [92.2%],P =.16)使用的 PIM 更少。在至少服用 1 种 PIM 的研究参与者中(n = 45),28.1%(n = 45)的 PIM 使用与入院有关或为入院的原因。
超过 80%的急性入院老年人在入院和出院时服用 PIM,其中超过四分之一的入院归因于 PIM 的使用。住院为全面药物审查提供了机会,加强这一过程的针对性干预措施可以减少 PIM 的使用和相关危害。